Blinklab Ltd (BB1) fair value: what the stock is really worth
As of Oct 5, 2026: fair value of Blinklab Ltd A$0.09, price A$0.66, upside -87.1%, quality 33 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.
How to read this chart
30‑month range A$0.2100 – A$1.09 · fair‑value band A$0.0595 – A$0.1105 · the A$0.6600 price screens above the A$0.0850 fair value. Dashed = 300-day average. As of Oct 4, 2026.
Follow Blinklab in your weekly email
Every Wednesday you see whether Blinklab is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations.
Show more
BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations. The company's application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Perth, Australia.
Stock analysis
Blinklab Ltd (BB1) currently trades at A$0.6600, while our model-based Fair Value estimate is A$0.0850, 87.1% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 92/100, which puts the evidence level at low.
Scenario range: A$0.0595 (bear) to A$0.1105 (bull), the price of A$0.6600 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 33/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Blinklab Ltd reported revenue of A$376K in FY2025 versus A$0 in FY2022. Reported net income was −A$7.2M in FY2026.
Key figures
Market cap A$116M (≈ $80.8M) · P/S ratio 96.4 · EPS (TTM) A$−0.0500 · Return on equity −50.7% · Return on assets (EBIT) −72.1% · Operating margin −319% · Revenue growth (YoY) +387% · Free cash flow −A$7.5M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).
What moves the price
The share trades about 39% below its 52-week high and 27% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −87%, BB1 screens richer than that median.
Fair Value models
Bear A$0.0595Fair Value A$0.0850Bull A$0.1105
Price A$0.6600 · Upside -87.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.24/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 117 stocks
Beats the industry median on 1/6 measures
Overall it trails its industry peers.
Valuation
Quality Score33 · Bottom 25%
Fair Value upside−87.1% · Bottom 25%
Profitability
Return on assets−29.1% · Bottom 25%
Growth and dividend
Revenue growth386.5% · Top 25%
Valuation Multiplesvs Health Information Services median · lower = cheaper
P/B4.14× · Priciest 25%
P/S (TTM)66.88× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 42
PAST (return on equity)0· sector 12
HEALTH (low debt)0· sector 98
DIVIDEND (yield)0· sector 44
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Blinklab Ltd Fair Value". https://www.fairvalue-calculator.com/stock/BB1
Frequently asked questions
Is Blinklab Ltd (BB1) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of A$0.0850 versus a price of A$0.6600, about −87% upside (overvalued).
What is the fair value of BB1?
Our model-based fair value for Blinklab Ltd is A$0.0850 (as of Oct 4, 2026), built from audited fundamentals. The current price: A$0.6600.
What is the quality score of BB1?
Blinklab Ltd has a Quality Score of 33/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Blinklab Ltd (BB1)?
Our model-based price target is the fair value of A$0.0850 (as of Oct 4, 2026) from 1 valuation models. Cautious scenario A$0.0595, optimistic scenario A$0.1105. It is a calculation from audited fundamentals, not an analyst target.
What is the Blinklab Ltd stock forecast for 2026?
Our models put fair value at A$0.0850, about −87% upside versus a price of A$0.6600 (overvalued). Cautious scenario A$0.0595, optimistic scenario A$0.1105. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Blinklab Ltd (BB1)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Blinklab Ltd it is A$0.0850 per share (as of Oct 4, 2026), against a price of A$0.6600. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Blinklab Ltd stock overvalued or undervalued in 2026?
As of Oct 4, 2026, BB1 trades above its calculated fair value: price A$0.6600, fair value A$0.0850, a gap of about −87% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BB1?
No. The price is what the market pays today (A$0.6600); the fair value is what the company's own numbers justify (A$0.0850). For Blinklab Ltd the two are A$0.5750 per share apart. That gap is exactly why we show both numbers side by side.
How much is Blinklab Ltd worth?
The market values Blinklab Ltd at about A$116M (market capitalisation, as of Oct 4, 2026). Per share that is A$0.6600; our models calculate a fair value of A$0.0850 per share.
What do the bullish and bearish scenarios say about BB1?
Our models span a range for Blinklab Ltd: cautious scenario A$0.0595, base A$0.0850, optimistic A$0.1105 per share (as of Oct 4, 2026, price A$0.6600). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Blinklab Ltd (BB1)?
Balance-sheet figures for Blinklab Ltd (as of Oct 4, 2026): return on equity −50.7%. They feed the Quality Score of 33/100, which measures business quality independently of the share price.
How far is BB1 from its 52-week high?
Blinklab Ltd trades at A$0.6600, about 39% below its 52-week high of A$1.09 and 27% above the low of A$0.5200 (as of Oct 5, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.0850 is for.
Which stocks are comparable to Blinklab Ltd?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Blinklab Ltd stock attractive at the current price?
The data as of Oct 4, 2026: price A$0.6600, calculated fair value A$0.0850 (−87%), Quality Score 33/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BB1 calculated?
We run Blinklab Ltd through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of A$0.0850, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. Blinklab Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Blinklab Ltd (BB1)?
The closing price on Oct 5, 2026 was A$0.6600. Our model-based fair value is A$0.0850, about −87% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Blinklab Ltd right now?
The price sits above even our optimistic bull case (A$0.1105). The favourable scenario is already priced in. Weak quality (33/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (A$0.0595 to A$0.1105) leaves room in how you read the outcome.
Key figures of Blinklab Ltd
How large is the market capitalisation of Blinklab Ltd (BB1)?
The market capitalisation of Blinklab Ltd is A$116M (≈ $80.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Blinklab Ltd (BB1)?
The price-to-sales ratio of Blinklab Ltd is 96.4 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Blinklab Ltd (BB1)?
Earnings per share at Blinklab Ltd are A$−0.0500. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Blinklab Ltd (BB1)?
The return on equity (ROE) of Blinklab Ltd is −50.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Blinklab Ltd (BB1)?
On an EBIT basis the return on assets of Blinklab Ltd is −72.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Blinklab Ltd (BB1)?
The operating margin of Blinklab Ltd is −319% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Blinklab Ltd (BB1)?
Revenue at Blinklab Ltd is growing +387% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Blinklab Ltd (BB1) generate?
The free cash flow of Blinklab Ltd is −A$7.5M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch Blinklab Ltd in the live analysis
One click puts Blinklab Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
